MedTrace Logo

Local Lidocaine Gel for Pain Management During

NCT07074626 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2025-07-20

No results posted yet for this study

Summary

Ultrasound is a very useful diagnostic tool in the obstetrics and gynecologic field. It is used to diagnose pelvic organs including the uterus, ovaries, tubes and endometrium, and can be used to evaluate gynecologic tumors regardless of their risk of malignant index. The types of pelvic sonography according to route include transvaginal sonography (TVS), transabdominal sonography (TAS), and transrectal sonography (TRS). Insertion of the probe into the vagina allows a very close and clear view of the pelvic organs, physicians have preferred TVS to TAS for accurate diagnosis of pelvic pathology .

Conditions

  • Ultrasound Diagnostics

Interventions

OTHER

transrectal ultrasound

A- Complete history was taking (personal, past, medical, surgical and family history) with careful attention to abdominal examination and suspected cause of pelvic pathology B- Through physical examination (general and abdominal examination). C- Investigations. * Trans-rectal ultrasound will be conducted to all the virgin patients as the standard US examination to detect the pelvic pathology * Patient anticipation for pain will be documented before the exam according to pain visual analogue scale (VAS) * Lidocaine gel will be used on the probe during TRU * The intensity of pain during trans-rectal US based on the pain visual analogue scale (0-10 ) points and the adverse events like extreme pain, inability to complete the examination and inability to detect the pathology will be reported.A Visual Analogue Scale (VAS) is one of the valided pain rating scales used for the first time in 1921 by Hayes and Patterson.

Sponsors & Collaborators

  • Suez University

    lead OTHER

Principal Investigators

  • Ahmed ElSherbiny · faculty of medicine, Suez university Suez, Suez, Egypt

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2025-09-01
Completion
2025-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07074626 on ClinicalTrials.gov